Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized

Pham, Danh; Bhandari, Shruti; Pinkston, Christina; Oechsli, Malgorzata; Kloecker, Goetz

doi:10.1016/j.cllc.2019.09.002

Cited by 79 publications

(55 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…35 Therefore, important questions remain about how LCS may be optimally delivered to underserved urban and rural populations. Although Patient Protection and Affordable Care Act provisions allow full coverage of LCS in primary care, it is substantially underutilized with reported prevalence of only about 6% or less, [36][37][38] and primary care clinicians' role seems unclear.…”

mentioning

confidence: 99%

Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action

et al. 2020

View full text Add to dashboard Cite

show abstract

mentioning

confidence: 99%

Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action

et al. 2020

View full text Add to dashboard Cite

show abstract

“…Services Task Force (USPSTF) in 2013 has been slow and limited, with currently (pre-covid) only an estimated 5-10% of eligibles undergoing LDCT screening 3 . Therefore, there is a critical need to employ strategies to substantially increase this rate.…”

Section: Uptake Of Ldct Screening Following the Initial B Recommendation Of The Us Preventivementioning

confidence: 99%

Electronic Health Records and Machine Learning for Early Detection of Lung Cancer and Other Conditions: Thinking about the Path Ahead

Pinsky

2021

Am J Respir Crit Care Med

View full text Add to dashboard Cite

“…47 , 48 However, only about 2% of eligible patients undergo screening. 49 This could be due to the lack of central co-ordination of screening programmes, but may also reflect limited interest in screening from eligible individuals.…”

Section: What Is Current Policy On Lung Cancer Screening?mentioning

confidence: 99%

What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?

2021

View full text Add to dashboard Cite

After the National Lung Screening Trial (NLST) 1 demonstrated improved lung cancer mortality almost a decade ago, hopes have been raised that low-dose computed tomography could be used to detect lung cancer in asymptomatic populations and improve outcomes by reducing the number of people diagnosed with advanced disease. The publication of the longawaited Nederlands-Leuvens Longkanker Screenings Onderzoek (NELSON) trial last year 2 has provided further evidence of a lung cancer mortality benefit and has provoked further calls to implement national population-based screening programmes, but the case for lung cancer screening remains controversial.

show abstract

Lung Cancer Screening Registry Reveals Low-dose CT Screening Remains Heavily Underutilized

Cited by 79 publications

References 13 publications

Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action

Lung Cancer Screening Guidelines Implementation in Primary Care: A Call to Action

Electronic Health Records and Machine Learning for Early Detection of Lung Cancer and Other Conditions: Thinking about the Path Ahead

What is the balance of benefits and harms for lung cancer screening with low-dose computed tomography?

Contact Info

Product

Resources

About